No results for ‘’
Natural Capsules Ltd
₹189.39
(0.71%)
Mon, 14 Sept 2026, 02:09 pm
Health Technology
Pharmaceuticals: Other
24.5KNatural Capsules Enterprise Value (EV)
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 5.29 | 4.43 | 4.12 | 1.53 | 4.18 | 4.13 | 3.73 | 2.32 | 3.84 | 6.38 | 16.14 | 77.62 | 58.15 | 21.10 | 23.88 | 9.70 | 23.29 | 19.76 | 51.18 | 293.45 |
| Price to book ratio | 1.12 | 0.82 | 0.64 | 0.31 | 0.77 | 0.69 | 0.61 | 0.40 | 0.41 | 0.79 | 1.12 | 0.91 | 1.19 | 0.73 | 0.37 | 1.08 | 5.21 | 2.96 | 1.40 | 0.82 |
| Price to sales ratio | 0.81 | 0.61 | 0.53 | 0.23 | 0.61 | 0.54 | 0.45 | 0.28 | 0.31 | 0.56 | 1.13 | 0.91 | 1.18 | 0.68 | 0.33 | 0.84 | 2.40 | 2.14 | 1.83 | 1.07 |
| Price to cash flow ratio | 4.96 | 5.48 | 3.89 | 1.72 | 2.58 | 4.17 | 3.77 | 2.37 | 2.86 | 6.50 | 22.30 | 32.99 | 12.29 | 20.17 | 3.03 | 4.79 | 257.46 | 22.58 | 0 | 12.85 |
| Enterprise value | 15.43Cr | 13.42Cr | 11.09Cr | 12.23Cr | 23.4Cr | 26.96Cr | 28.75Cr | 24.53Cr | 23.23Cr | 41.28Cr | 75.37Cr | 51.4Cr | 63.6Cr | 45.42Cr | 26.71Cr | 75.14Cr | 370Cr | 479Cr | 405Cr | 305Cr |
| Enterprise value to EBITDA ratio | 3.41 | 2.83 | 2.01 | 1.66 | 3.01 | 3.02 | 2.98 | 2.67 | 2.54 | 4.52 | 7.73 | 10 | 11.46 | 8.97 | 4.88 | 6.54 | 14.62 | 13.92 | 20.91 | 16.94 |
| Debt to equity ratio | 0.26 | 0.21 | 0.07 | 0.32 | 0.25 | 0.33 | 0.32 | 0.28 | 0.14 | 0.12 | 0.10 | 0.05 | 0 | 0.10 | 0.13 | 0.17 | 0.62 | 0.79 | 0.53 | 0.45 |
| Return on equity % | 0 | 20.06 | 17.62 | 22.34 | 20.05 | 17.86 | 17.43 | 18.63 | 11.48 | 12.59 | 8.44 | 1.14 | 1.96 | 3.50 | 1.54 | 11.74 | 19.18 | 17.89 | 3.40 | 0.28 |
Natural Capsules Ltd Enterprise Value
The Natural Capsules Ltd Enterprise Value is a key financial metric used by investors to evaluate Natural Capsules Ltd's valuation, profitability, and overall financial performance. Tracking the Natural Capsules Ltd Enterprise Value helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Natural Capsules Ltd (NSE: NATCAPSUQ, BSE: 524654) is currently trading at ₹189.39, with a market capitalization of ₹196.25Cr. As a leading company in the Health technology sector and Pharmaceuticals: other industry, monitoring the Natural Capsules Ltd Enterprise Value is essential for fundamental analysis.
Natural Capsules Ltd Enterprise Value Current Value
The current Natural Capsules Ltd Enterprise Value stands at 305Cr.
The Natural Capsules Ltd Enterprise Value has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.
Natural Capsules Ltd Enterprise Value Historical Trend
The Natural Capsules Ltd Enterprise Value has shown the following historical trend:
- 2024: 305Cr
- 2023: 405Cr
- 2022: 479Cr
- 2021: 370Cr
- 2020: 75.14Cr
The decline in Natural Capsules Ltd Enterprise Value indicates improving financial efficiency or better earnings growth.
What Natural Capsules Ltd Enterprise Value Indicates for Investors
The Natural Capsules Ltd Enterprise Value plays a crucial role in understanding the company's financial health and valuation.
This ratio is an important metric used in fundamental analysis of Natural Capsules Ltd.
Natural Capsules Ltd Enterprise Value Analysis Summary
The Natural Capsules Ltd Enterprise Value remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Natural Capsules Ltd Enterprise Value should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Natural Capsules Ltd Enterprise Value helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.